Pace Analytical Life Sciences, LLC, a subsidiary of Pace Analytical® Services, LLC, a full-service contract development and manufacturing organization (CDMO), announced Tuesday that it has acquired Bio-Concept Laboratories, Inc., a pharmaceutical CDMO specializing in formulation development and fill-finish manufacturing of sterile aqueous products. “Pace clients have been asking us to add sterile materials for clinical trials to our CDMO capabilities,” said Eric Roman, Pace Analytical CEO. “Bringing Bio-Concept Laboratories onboard allows us to respond to that demand while increasing our capacity to service the market throughout the drug delivery life cycle – from formulation research and development to pre-clinical and clinical trial materials.”
Read the full article: Pace Analytical® Expands CDMO Capabilities with Bio-Concept Laboratories Acquisition //
Source: https://www.prweb.com/releases/pace_analytical_expands_cdmo_capabilities_with_bio_concept_laboratories_acquisition/prweb17591434.htm